EVAX News and Press, Evaxion Biotech A/S From 10/17/25

A look at the top 10 most actives in the United States Rani Therapeutics Holdings Inc. (RANI) rose 248.3% to $1.64 on volume of 482,613,416 shares Beyond Meat Inc. (BYND) rose 24.2% to $0.6456 on volume of 419,584,353 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 1.0% to $4...

A look at the top 10 most actives in the United States Rani Therapeutics Holdings Inc. (RANI) rose 158.0% to $1.215 on volume of 150,083,425 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 3.9% to $4.175 on volume of 72,025,447 shares Bitfarms Ltd. (BITF) fell 8.5% to $4.83 o...

2025-10-17 09:50:31 ET https://markets-headlines.com/wp-content/uploads/2025/10/Natural-Killer-Cell-Therapies-Lead-254B-Immunotherapy-Market-Transformation.mp4 Equity Insider News Commentary Issued on be...

75% Objective Response Rate as 12 out of 16 advanced melanoma patients had objective clinical responses, with 11 of the 12 responders continuing to respond at 24 months follow-up Immune activation observed in all patients with 81% of EVX-01’s vaccine targets triggering a specific r...

Presentation will cover two-year clinical efficacy, immunogenicity and safety data Data will be presented at an oral session on October 17, 2025, followed by a webinar on October 22, 2025, providing further insights into the clinical findings COPENHAGEN, Denmark, October 13, 2025 ...

New platform module automates previous manual vaccine design processes, improving quality and dramatically reducing time and resource requirements AI-Immunology™, already superior in vaccine target discovery, now also enables enhanced design applicable for both new vaccines and opt...

New biomarker and immune data from the ongoing phase 2 trial with EVX-01 will be presented at the Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting The data will be the latest of many additions to EVX-01’s strong data package Two-year clinical efficacy data fro...

2025-09-25 11:07:46 ET Evaxion A/S - Special Call Company Participants Birgitte Rono - Interim CEO & Chief Scientific Officer Thomas Schmidt - Chief Financial Officer ... Read the full article on Seeking Alpha For further details see: Evaxion A/S ...

A look at the top 10 most actives in the United States PLUS THERAPEUTICS Inc. (PSTV) rose 40.1% to $0.566449 on volume of 188,869,548 shares WORK Medical Technology Group LTD (WOK) rose 24.5% to $0.1401 on volume of 174,167,557 shares PepGen Inc. (PEPG) rose 112.6% to $5.6557 on volume of 6...

2025-09-25 09:08:52 ET DENVER, Colo., Sep 25, 2025 ( 247marketnews.com )- VENU (NYSE:VENU) is fueled by a Younger Associates report projecting $17.6 billion in economic impact and 4,700 jobs over 20 years from venues like Sunset McKinney ($5.9B, 1,463 jobs) and El Paso ($5.4B, 2,100...